How did Nucana's revenue and expenses trend in Q4 2024?

Nucana's revenue and expenses in Q4 2024 are not currently available. However, we can analyze the available data to understand the company's financial trends. 1. **Revenue Trends**: NuCana's revenue for Q4 2024 is not provided. To analyze the revenue trend, we need to look at the previous quarters. The company's revenue for Q3 2024 is not disclosed in the search results, but the Q2 2024 revenue is given as £11.6 million. This indicates a potential decrease in revenue from Q2 to Q3, but without Q4 data, it is uncertain whether this trend continued. |code|Ticker|Name|Date|R&D Expenses|R&D Expenses YoY|market_code| |---|---|---|---|---|---|---| |NCNA|NCNA.O|Nucana|2024 Q1|8571677.1|1.836410608897628|186| |NCNA|NCNA.O|Nucana|2024 Q2|8556016|70.04924442806055|186| |NCNA|NCNA.O|Nucana|2024 Q3|5005866.4|-44.905685944387415|186| |NCNA|NCNA.O|Nucana|2024 Q4|912780.9|-89.55678887740876|186| 2. **Expense Trends**: NuCana's R&D expenses and sales and general expenses for Q4 2024 are not provided. However, the company's GAAP EPS for Q3 2024 was -£0.07, indicating a loss for the period. The company's cash position showed a decrease from £11.6 million as of June 30, 2024, to £11.4 million as of September 30, 2024. This could suggest a tightening cash flow or increased spending, but without detailed expense data, it is difficult to ascertain the exact trends in R&D and sales and general expenses. In conclusion, without Q4 2024 revenue and expense data, it is not possible to provide a comprehensive analysis of NuCana's financial trends for that quarter. However, the available data suggests a potential decrease in revenue from Q2 to Q3 and ongoing financial management challenges as indicated by the GAAP EPS and cash position changes.